Company intelligence / Profile preview

Honor Epic Enterprises Limited

British Virgin Islands

Ownership: Private
Development stage: Other

Overview

Honor Epic Enterprises Limited is a British Virgin Islands-registered investment entity primarily known through its 2021 joint venture with Regencell Bioscience Holdings Limited (NASDAQ: RGC), a TCM bioscience company developing treatments for ADHD, ASD, and COVID-19. It is controlled by Ji Yang Lee and focuses on commercializing TCM therapies in Asia-Pacific regions, but has no independent pipeline, website, or public financials disclosed.

Industry: Investors

Partnerships

Regencell Bioscience Holdings Limited

Beyond the preview

Go deeper on Honor Epic Enterprises Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Honor Epic Enterprises Limited.

Explore the full profile